BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M Turnover 16.91%
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$9.81M
Cap. Flow
+$3.88M
Cap. Flow %
2.93%
Top 10 Hldgs %
31.07%
Holding
141
New
8
Increased
35
Reduced
44
Closed
7
Avg Time Held Equity + Options
2.1 years
Top 10 Avg Time Held Equity + Options
1.1 years
Top 20 Avg Time Held Equity + Options
1.7 years
Avg Time Held Equity only
2.1 years
Top 10 Avg Time Held Equity only
1.1 years
Top 20 Avg Time Held Equity only
1.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.21%
2 Real Estate 16.84%
3 Healthcare 12.91%
4 Technology 12.84%
5 Financials 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TEVA icon
51
Teva Pharmaceutical Industries Limited
TEVA
$47.5B
$712K 0.54%
15,469
– –
2016 Q1
2 quarters
VXX icon
52
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$705K 0.53%
5,175
+4,081
+373% +$652K
2016 Q1
2 quarters
ROIC icon
53
DELISTED
Retail Opportunity Investments Corp.
ROIC
$692K 0.52%
31,500
– –
2013 Q2
13 quarters
SAFE icon
54
Safehold
SAFE
$818M
$680K 0.51%
13,015
+1,212
+10% +$61.9K
2013 Q2
13 quarters
AMGN icon
55
Amgen
AMGN
$230B
$669K 0.51%
4,008
– –
2015 Q4
3 quarters
BRK.A icon
56
Berkshire Hathaway Class A
BRK.A
$1.13T
$649K 0.49%
3
– –
2014 Q1
10 quarters
MS.PRA icon
57
Morgan Stanley Series A Preferred Stock
MS.PRA
$757M
$614K 0.46%
25,305
– –
2013 Q2
13 quarters
MET.PRA icon
58
MetLife Inc Floating Rate Series A
MET.PRA
$505M
$613K 0.46%
24,100
– –
2013 Q2
13 quarters
DEM icon
59
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.14B
$577K 0.44%
15,349
-800
-5% -$30.2K
2014 Q1
10 quarters
DIAX icon
60
DELISTED
Nuveen Dow 30SM Dynamic Overwrite Fund
DIAX
$569K 0.43%
39,489
– –
2014 Q4
7 quarters
RGLD icon
61
Royal Gold
RGLD
$19.1B
$565K 0.43%
7,300
– –
2013 Q4
11 quarters
CCEC icon
62
Capital Clean Energy Carriers
CCEC
$1.24B
$556K 0.42%
24,366
+2,286
+10% +$55.1K
2013 Q2
13 quarters
BNBX
63
DELISTED
BNB PLUS CORP
BNBX
– –
0
– –
2015 Q2
5 quarters
MUC icon
64
BlackRock MuniHoldings California Quality Fund
MUC
$1.2B
$529K 0.4%
33,000
+3,000
+10% +$48.5K
2013 Q2
13 quarters
COP icon
65
ConocoPhillips
COP
$171B
$523K 0.39%
12,027
-1,950
-14% -$81K
2013 Q2
13 quarters
SNY icon
66
Sanofi
SNY
$95.3B
$502K 0.38%
13,150
-450
-3% -$18.1K
2015 Q1
6 quarters
MCR
67
DELISTED
MFS Charter Income Trust
MCR
$481K 0.36%
55,650
-1,000
-2% -$8.61K
2013 Q2
13 quarters
AIG icon
68
American International
AIG
$40.5B
$445K 0.34%
7,500
– –
2013 Q2
13 quarters
JNJ icon
69
Johnson & Johnson
JNJ
$612B
$407K 0.31%
3,448
+400
+13% +$48.5K
2013 Q2
13 quarters
WBA icon
70
DELISTED
Walgreens Boots Alliance
WBA
$403K 0.3%
5,000
-33
-0.7% -$2.69K
2016 Q2
1 quarter
ALLY icon
71
Ally Financial
ALLY
$11.2B
$399K 0.3%
20,500
-2,500
-11% -$46.5K
2015 Q3
4 quarters
VTNR icon
72
DELISTED
Vertex Energy, Inc
VTNR
$395K 0.3%
343,469
-500
-0.1% -$631
2013 Q2
13 quarters
AMZN icon
73
Amazon
AMZN
$2.74T
$383K 0.29%
9,140
– –
2016 Q2
1 quarter
RDI icon
74
Reading International Class A
RDI
$40.3M
$382K 0.29%
28,600
– –
2013 Q2
13 quarters
DIS icon
75
Walt Disney
DIS
$188B
$376K 0.28%
4,050
-18
-0.4% -$1.72K
2013 Q2
13 quarters

Similar funds

Benchmark Capital Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Benchmark Capital Advisors held 141 positions worth $132M, up 8% from $123M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Benchmark Capital Advisors's Q3 2016 filing shows 8 new, 35 increased, 44 reduced and 7 closed positions. Its largest new stake was Alibaba: 17,570 shares worth $1.86M. The largest sale was Sarepta Therapeutics, an estimated $1.73M.

By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 18% a quarter earlier, followed by Real Estate and Healthcare.

  • Benchmark Capital Advisors's largest Q3 2016 buy was Alibaba: 17,570 shares worth $1.86M.
  • Benchmark Capital Advisors added most to Meta Platforms (Facebook) in Q3 2016, an estimated $1.55M increase.
  • Benchmark Capital Advisors's biggest Q3 2016 reduction was Sarepta Therapeutics, cutting an estimated $1.73M.
  • Benchmark Capital Advisors fully exited Johnson Controls International in Q3 2016, selling an estimated $821K.
  • Benchmark Capital Advisors's ten largest holdings make up 31% of its $132M portfolio in Q3 2016.
  • Benchmark Capital Advisors opened 8 new positions and closed 7 in Q3 2016.
  • Benchmark Capital Advisors's portfolio value rose 8% quarter-over-quarter to $132M.

Based on Benchmark Capital Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.